Syndax Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 8.24 M | $158.60 M | 100.00% | 9.64% |
KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 5.84 M | $112.48 M | 2.11% | 6.84% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 4.99 M | $95.98 M | -32.06% | 5.84% |
VANGUARD GROUP INC | 11/13/2024 | 4.89 M | $94.07 M | 1.87% | 5.72% |
EVERSEPT PARTNERS, LP | 11/14/2024 | 4.11 M | $79.03 M | 13.61% | 4.81% |
AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 3.89 M | $74.85 M | 0.00% | 4.55% |
STATE STREET CORP | 11/14/2024 | 3.77 M | $72.59 M | 4.10% | 4.41% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 2.78 M | $53.48 M | -0.16% | 3.25% |
AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 2.46 M | $47.26 M | -26.39% | 2.87% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.98 M | $38.07 M | 3.48% | 2.31% |
ORBIMED ADVISORS LLC | 11/14/2024 | 1.93 M | $37.06 M | 0.00% | 2.25% |
WOODLINE PARTNERS LP | 11/14/2024 | 1.90 M | $36.50 M | 22.68% | 2.22% |
FRANKLIN RESOURCES INC | 11/27/2024 | 1.76 M | $34.95 M | 13.38% | 2.06% |
STEMPOINT CAPITAL LP | 11/13/2024 | 1.73 M | $33.33 M | 22.59% | 2.03% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.61 M | $31.03 M | 11.64% | 1.89% |
FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 1.19 M | $22.85 M | 85.38% | 1.39% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.12 M | $21.56 M | 5.11% | 1.31% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 1.09 M | $21.00 M | 32.00% | 1.28% |
SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 1.03 M | $19.92 M | 25.89% | 1.21% |
AISLING CAPITAL MANAGEMENT LP | 11/13/2024 | 1.03 M | $19.73 M | 0.00% | 1.20% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 11/14/2024 | 1.00 M | $19.25 M | 11.73% | 1.17% |
CANDRIAM S.C.A. | 11/13/2024 | 998,619 | $19.22 M | 2.94% | 1.17% |
MARSHALL WACE, LLP | 11/14/2024 | 989,904 | $19.06 M | -45.92% | 1.16% |
MORGAN STANLEY | 11/14/2024 | 887,145 | $17.08 M | 17.31% | 1.04% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 886,494 | $17.07 M | -4.78% | 1.04% |
COMMODORE CAPITAL LP | 11/14/2024 | 885,000 | $17.04 M | 7.27% | 1.04% |
FORESITE CAPITAL MANAGEMENT IV, LLC | 11/14/2024 | 875,000 | $16.84 M | 0.00% | 1.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 817,600 | $15.74 M | -4.93% | 0.96% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/08/2024 | 787,785 | $15.17 M | 100.00% | 0.92% |
SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 786,999 | $15.15 B | -63.46% | 0.92% |
EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 786,990 | $15.15 M | 100.00% | 0.92% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 757,307 | $14.58 M | -11.14% | 0.89% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 695,947 | $13.40 M | 6.33% | 0.81% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 683,202 | $13.15 M | 129.80% | 0.80% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 669,352 | $12.89 M | 7.74% | 0.78% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 664,765 | $12.80 M | 11.84% | 0.78% |
JPMORGAN CHASE & CO | 11/08/2024 | 627,679 | $12.08 M | -0.35% | 0.73% |
PROSIGHT MANAGEMENT, LP | 11/14/2024 | 554,103 | $10.67 M | 0.46% | 0.65% |
DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 526,702 | $10.14 M | -19.84% | 0.62% |
PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 508,283 | $9.78 M | -15.38% | 0.59% |
SATURN V CAPITAL MANAGEMENT LLC | 11/14/2024 | 501,978 | $9.66 M | 19.62% | 0.59% |
POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 500,000 | $9.63 M | 100.00% | 0.59% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 486,228 | $9.36 M | -6.69% | 0.57% |
CASDIN CAPITAL, LLC | 11/14/2024 | 475,000 | $9.14 M | 216.67% | 0.56% |
ALGERT GLOBAL LLC | 11/12/2024 | 474,998 | $9.14 M | 9.92% | 0.56% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 466,028 | $8.97 M | 8.64% | 0.55% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 459,532 | $8.85 M | -17.41% | 0.54% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 453,232 | $8.72 M | 0.00% | 0.53% |
GHOST TREE CAPITAL, LLC | 11/14/2024 | 450,000 | $8.66 M | 28.57% | 0.53% |
CRESTLINE MANAGEMENT, LP | 11/13/2024 | 428,538 | $8.25 M | 199.09% | 0.50% |
Syndax Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 248 institutional investors and hedge funds held shares of Syndax Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 8.24 M
Kynam Capital Management, LP: 5.84 M
WELLINGTON MANAGEMENT GROUP LLP: 4.99 M
VANGUARD GROUP INC: 4.89 M
Eversept Partners, LP: 4.11 M
Avoro Capital Advisors LLC: 3.89 M
104.05% of Syndax Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 96.76 M shares in the last 24 months. This purchase volume represents approximately $1.26 B in transactions.